|
2013 Journal Article Abnormal laboratory results: anti-Xa assaysBarras, Michael (2013). Abnormal laboratory results: anti-Xa assays. Australian Prescriber, 36 (3), 98-101. doi: 10.18773/austprescr.2013.036 |
|
2013 Conference Publication Implementation and Evaluation of an Interprofessional CurriculumCottrell, Neil, Waller, Susan, Barras, Michael, Burston, Adam, Dickie, Robyn, Groves, Michele, Kendall, Bradley and Rylands, Linda (2013). Implementation and Evaluation of an Interprofessional Curriculum. Collaborating Across Borders III (CAB III) Interprofessional Collaboration: From Concept to Preparation to Practice, Tucson, AZ, United States, 19-21 November 2011. London, United Kingdom: Informa Healthcare. doi: 10.3109/13561820.2013.761518 |
|
2012 Journal Article Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?Iedema, Joel, Barras, Michael, Sundac, Lana and Coombes, Ian (2012). Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?. Australian Prescriber, 35 (2), 64-65. doi: 10.18773/austprescr.2012.029 |
|
2012 Journal Article Gentamicin use - more clinical outcome evidence neededMartin, Jennifer, Norris, Ross and Barras, Michael (2012). Gentamicin use - more clinical outcome evidence needed. Journal of Clinical Toxicology, 2 (6), e110.1-e110.2. doi: 10.4172/2161-0495.1000e110 |
|
2012 Journal Article Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trialMartin, Jennifer, Barras, Michael, Yui, Nicholas Ah, Kirkpatrick, Carl, Kubler, Paul and Norris, Ross (2012). Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. Journal of Clinical Toxicology, 2 (8), 146.1-146.5. doi: 10.4172/2161-0495.1000146 |
|
2011 Journal Article Recurrent readmissions in medical patients: A prospective studyMudge, AM, Kasper, K, Clair, A, Redfern, H, Bell, JJ, Barras, MA, Dip, G and Pachana, NA (2011). Recurrent readmissions in medical patients: A prospective study. Journal of Hospital Medicine, 6 (2), 61-67. doi: 10.1002/jhm.811 |
|
2011 Conference Publication Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosisNorris, R. L. G., Barras, M., Alraman, H., Kirkpatrick, C., Dakin, C., Harris, M. and Jess, K. (2011). Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba |
|
2011 Journal Article Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosisBarras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x |
|
2010 Journal Article Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional developmentNorris, Ross L., Martin, Jennifer H., Thompson, Erin, Ray, John E., Fullinfaw, Robert O., Joyce, David, Barras, Michael, Jones, Graham R. and Morris, Raymond G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32 (5), 615-623. doi: 10.1097/FTD.0b013e3181ea3e8a |
|
2010 Journal Article Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrationsBarras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846 |
|
2010 Journal Article Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international surveyBarras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010). Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 (5), 520-528. doi: 10.1111/j.1365-2125.2010.03626.x |
|
2010 Journal Article Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMartin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24. |
|
2010 Journal Article Routine plasma anti-Xa monitoring is required for low-molecular-weight heparinsAl-Sallami, Hesham S., Barras, Michael A., Green, Bruce and Duffull, Stephen B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49 (9), 567-571. doi: 10.2165/11532960-000000000-00000 |
|
2009 Other Outputs Dose individualisation of enoxaparinMichael Barras (2009). Dose individualisation of enoxaparin. PhD Thesis, Pharmacy school, The University of Queensland. |
|
2009 Conference Publication The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s diseaseO’Maley, Karen A., O’Sullivan, John D., Wollin, Judy and Barras, Michael (2009). The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease. Australian and New Zealand Association of Neurologists (ANZAN) 2008 Annual Scientific Meeting, Australia, 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2008.07.043 |
|
2009 Journal Article Myalgia in patients on high-dose and low-to-moderate dose statin therapyGujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009). Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 (3), 202-206. doi: 10.1002/j.2055-2335.2009.tb00453.x |
|
2009 Book Chapter Dose individualization of drugs based on body compositionBarras, Michael and Green, Bruce (2009). Dose individualization of drugs based on body composition. Heart disease in men. (pp. 219-242) edited by Alice B. Todd and Margo H. Mosley. New York, NY, United States: Nova Science Publishers. |
|
2009 Journal Article Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising eventsBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x |
|
2009 Journal Article Preliminary results of a therapeutic drug monitoring survey in AustralasiaNorris, R. L., Morris, R. G., Ray, J. E., Fullinfaw, R. O., Ilett, K. F., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2009). Preliminary results of a therapeutic drug monitoring survey in Australasia. Pathology, 41 (s1), 71-71. doi: 10.1097/01268031-200941001-00167 |
|
2009 Conference Publication A survey of therapeutic drug monitoring in AustralasiaNorris, Ross, Morris, Ray, Thompson, Erin, Ray, John, Barras, Michael, Jones, Graham and Martin, Jenny (2009). A survey of therapeutic drug monitoring in Australasia. 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montréal, QC, Canada, 3-8 October 2009. New York, NY, U.S.A.: Lippincott-Raven. doi: 10.1097/FTD.0b013e3181b7997b |
